Form 4: Astrana Health Director Mitchell W. Kitayama Reports Stock Option Exercise and Share Disposals

Sentiment:

SEC Form 4 Filing


Director Mitchell W. Kitayama exercised stock options and disposed of shares of Astrana Health, Inc. on September 10, 2024.

Summary

  • On September 10, 2024, Mitchell W. Kitayama, a director of Astrana Health, Inc., exercised stock options to acquire 11,000 shares of common stock at a price of $15.35 per share.
  • Following the exercise, Kitayama disposed of 3,522 shares to cover tax obligations at a price of $47.93.
  • After these transactions, Kitayama directly owns 17,792 shares of Astrana Health common stock.
  • This includes 6,750 shares of restricted stock vesting on December 9, 2024, and 3,564 shares vesting on August 13, 2025, or the date of the 2025 annual meeting.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider transactions, with no inherent positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors. It's common for executives to exercise stock options and sell a portion of the acquired shares to cover taxes.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership by a company director.

Key Dates

DateDescription
09/10/2024Date of stock option exercise and share disposal.
10/11/2024Expiration date of the stock options.
12/09/2024Vesting date for 6,750 shares of restricted stock.
08/13/2025Vesting date for 3,564 shares of restricted stock, or the date of the 2025 annual meeting.
09/11/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.